Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders

REFERENCES

1. 1.↵
   2. Poloni G,
   3. Minagar A,
   4. Haacke EM, et al

   . Recent developments in imaging of multiple sclerosis. Neurologist 2011;17:185–204

   CrossRefPubMed
2. 2.↵
   2. Filippi M,
   3. Rocca MA,
   4. De Stefano N, et al

   . Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 2011;68:1514–20

   CrossRefPubMed
3. 3.↵
   2. Barkhof F

   . The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15:239–45

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Barkhof F

   . MRI in multiple sclerosis: correlation with Expanded Disability Status Scale (EDSS). Mult Scler 1999;5:283–86

   Abstract/FREE Full Text
5. 5.↵
   2. Miller DH,
   3. Barkhof F,
   4. Nauta JJ

   . Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993;116(pt 5):1077–94

   Abstract/FREE Full Text
6. 6.↵
   2. Rovaris M,
   3. Holtmannspotter M,
   4. Rocca MA, et al

   . Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study. Mult Scler 2002;8:52–58

   Abstract/FREE Full Text
7. 7.↵
   2. Polman CH,
   3. Reingold SC,
   4. Banwell B, et al

   . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Govoni M,
   3. Castellino G,
   4. Padovan M, et al

   . Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus. Lupus 2004;13:149–58

   Abstract/FREE Full Text
9. 9.↵
   2. Triulzi F,
   3. Scotti G

   . Differential diagnosis of multiple sclerosis: contribution of magnetic resonance techniques. J Neurol Neurosurg Psychiatry 1998;64(suppl 1):S6–14

   CrossRefPubMed
10. 10.↵
    2. Zivadinov R,
    3. Bergsland N,
    4. Stosic M, et al

    . Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis. Neurol Res 2008;30:816–26

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Yao B,
    3. Bagnato F,
    4. Matsuura E, et al

    . Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 2012;262:206–15

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Hagemeier J,
    3. Heininen-Brown M,
    4. Poloni GU, et al

    . Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study. J Magn Reson Imaging 2012;36:73–83

    CrossRefPubMed
13. 13.↵
    2. Bian W,
    3. Harter K,
    4. Hammond-Rosenbluth KE, et al

    . A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. Mult Scler 2013;19:69–75

    Abstract/FREE Full Text
14. 14.↵
    2. Haacke EM,
    3. Makki M,
    4. Ge Y, et al

    . Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537–44

    CrossRefPubMed
15. 15.↵
    2. Zivadinov R,
    3. Heininen-Brown M,
    4. Schirda CV, et al

    . Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 2012;59:331–39

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Langkammer C,
    3. Krebs N,
    4. Goessler W, et al

    . Susceptibility induced gray-white matter MRI contrast in the human brain. Neuroimage 2012;59:1413–19

    CrossRefPubMed
17. 17.↵
    2. Yablonskiy DA,
    3. Luo J,
    4. Sukstanskii AL, et al

    . Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis. Proc Natl Acad Sci U S A 2012;109:14212–17

    Abstract/FREE Full Text
18. 18.↵
    2. Schweser F,
    3. Deistung A,
    4. Lehr BW, et al

    . Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011;54:2789–807

    CrossRefPubMed
19. 19.↵
    2. Hagemeier J,
    3. Geurts JJ,
    4. Zivadinov R

    . Brain iron accumulation in aging and neurodegenerative disorders. Expert Rev Neurother 2012;12:1467–80

    CrossRefPubMed
20. 20.↵
    2. Wiggermann V,
    3. Hernandez Torres E,
    4. Vavasour IM, et al

    . Magnetic resonance frequency shifts during acute MS lesion formation. Neurology 2013;81:211–18

    CrossRef
21. 21.↵
    2. Craelius W,
    3. Migdal MW,
    4. Luessenhop CP, et al

    . Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982;106:397–99

    PubMedWeb of Science
22. 22.↵
    2. Ferguson B,
    3. Matyszak MK,
    4. Esiri MM, et al

    . Axonal damage in acute multiple sclerosis lesions. Brain 1997;120(pt 3):393–99

    Abstract/FREE Full Text
23. 23.↵
    2. Trapp BD,
    3. Ransohoff R,
    4. Rudick R

    . Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295–302

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Grabner G,
    3. Dal-Bianco A,
    4. Schernthaner M, et al

    . Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI. J Magn Reson Imaging 2011;33:543–49

    CrossRefPubMed
25. 25.↵
    2. Nathoo N,
    3. Agrawal S,
    4. Wu Y, et al

    . Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination. Mult Scler 2013;19:721–31

    Abstract/FREE Full Text
26. 26.↵
    2. O'Connor K,
    3. Weinstock-Guttman B,
    4. Carl E, et al

    . Patterns of dietary and herbal supplement use by multiple sclerosis patients. J Neurol 2012;259:637–44

    CrossRefPubMed
27. 27.↵
    2. Foster M,
    3. Zivadinov R,
    4. Weinstock-Guttman B, et al

    . Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis. J Neuroimmunol 2012;243:61–68

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Jenkinson M,
    3. Smith S

    . A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143–56

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Zivadinov R,
    3. Rudick RA,
    4. De Masi R, et al

    . Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001;57:1239–47

    CrossRef
30. 30.↵
    2. Polman CH,
    3. Reingold SC,
    4. Edan G, et al

    . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria.” Ann Neurol 2005;58:840–46

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Benjamini Y,
    3. Hochberg Y

    . Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 1995;57:289–300

    CrossRefWeb of Science
32. 32.↵
    2. Mehta V,
    3. Pei W,
    4. Yang G, et al

    . Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One 2013;8:e57573

    CrossRefPubMed
33. 33.↵
    2. Eissa A,
    3. Lebel RM,
    4. Korzan JR, et al

    . Detecting lesions in multiple sclerosis at 4.7 Tesla using phase susceptibility-weighting and T2-weighting. J Magn Reson Imaging 2009;30:737–42

    CrossRefPubMed
34. 34.↵
    2. Rovaris M,
    3. Filippi M

    . Diffusion tensor MRI in multiple sclerosis. J Neuroimaging 2007;17(suppl 1):27S–30S

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Richards TL

    . Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR Am J Roentgenol 1991;157:1073–78

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Tan IL,
    3. van Schijndel RA,
    4. Pouwels PJ, et al

    . MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1039–42

    Abstract/FREE Full Text
37. 37.↵
    2. Tallantyre EC,
    3. Morgan PS,
    4. Dixon JE, et al

    . A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009;44:491–94

    CrossRefPubMed